Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	12/15/2005 3:41:01 PM
	Read Replies (1) of 3158

Bristol and Medarex ? <<<<<<<<<<<<<<<< "The theme here is bigger biotech or pharma companies joining with smaller companies for cancer drugs," said Monane, adding that companies working on Phase III cancer drug candidates were particularly attractive takeover candidates. Monane said several other existing collaborations could also end up as mergers, including Bristol-Myers (BMY: Bristol-Myers Squibb Company and Medarex; Bayer AG (BAY: Bayer AG and Onyx Pharmaceuticals (ONXX: ONYX Pharmaceuticals Inc and Schering AG (SHR: schering a g sponsored and Sonus Pharmaceuticals. (SNUS: SONUS "There are going to be more of these deals," said Monane <<<<<<<<<<<<<<<<<<<<<<<< marketwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next